FDA’s Generic Drug Labeling Proposed Rule: Best Practices for Generic, Innovator, and Biosimilars Manufacturers to Combat Anticipated Plaintiffs’ Tactics

Bradley partner Kevin Newsome spoke at the ACI Drug & Medical Device Litigation Conference in New York City. The 20th anniversary of ACI’s flagship Drug and Med conference is a forum designed to facilitate discussion of the opportunities before defense litigators to better advocate on behalf of life-saving and life-improving drug and device companies. Drug and medical device product liability litigators offered practical advice on crafting the most effective defenses in mass tort litigation in response to the latest legal challenges.